MFDS Expands Smart Orthotics Exemption to Include GB/T 24625-2025

On May 17, 2026, the Korean Ministry of Food and Drug Safety (MFDS) updated its Smart Orthotics Import Compliance Notice, extending regulatory exemption for materials used in smart orthotics — specifically accepting China’s national standard GB/T 24625-2025, Technical Requirements for Carbon Fiber Reinforced Polymer Orthotic Materials. This change enables importers to bypass redundant biocompatibility testing in Korea, shortening certification timelines by 22 working days. Medical device exporters, material suppliers, and orthotics manufacturers targeting the Korean market should monitor implications closely.

Event Overview

On May 17, 2026, the Korean Ministry of Food and Drug Safety (MFDS) issued an update to its Smart Orthotics Import Compliance Notice. The revision explicitly states that smart orthotics incorporating carbon fiber-reinforced polymer materials compliant with China’s GB/T 24625-2025 standard are now eligible for exemption from mandatory local biocompatibility retesting. The exemption takes effect immediately upon publication. No additional conditions or transitional provisions were disclosed in the official notice.

Industries Affected

Direct Exporters of Smart Orthotics
These companies face reduced time-to-market for Korean imports, as the exemption eliminates a major bottleneck in MFDS registration. Impact is most pronounced for exporters whose products already conform to GB/T 24625-2025 — they may now submit documentation referencing this standard directly, without initiating parallel Korean biocompatibility studies.

Carbon Fiber Composite Material Suppliers
Suppliers certifying raw or semi-finished carbon fiber-reinforced polymer materials under GB/T 24625-2025 gain enhanced value proposition for downstream orthotics manufacturers serving the Korean market. Demand for traceable, standard-compliant batches may increase, especially where material-level certification supports final device submissions.

Orthotics Contract Manufacturers & OEMs
Manufacturers producing devices for global brands must verify whether their current material sourcing aligns with GB/T 24625-2025. Non-compliant supply chains may require requalification or substitution to leverage the exemption — potentially affecting production scheduling and cost structures.

Distribution & Regulatory Support Providers
Local Korean agents and regulatory consultants handling MFDS submissions will need to update internal checklists and client guidance to reflect the new acceptance criteria. Misapplication of the exemption — e.g., citing GB/T 24625-2025 for non-carbon-fiber materials or unverified batches — could lead to submission rejection.

Key Considerations and Recommended Actions

Monitor Official Implementation Guidance

The MFDS notice confirms eligibility but does not specify required evidence formats (e.g., test reports, certificates of conformity, or third-party verification). Exporters and suppliers should track any follow-up announcements or Q&A documents issued by MFDS or Korean notified bodies.

Verify Alignment Between Product Design and Standard Scope

GB/T 24625-2025 applies specifically to carbon fiber–reinforced polymer orthotic materials — not finished devices or other composite types. Companies must ensure that the certified material grade, manufacturing process, and intended use match the scope defined in the standard before claiming exemption.

Distinguish Policy Signal from Operational Readiness

While the exemption is effective immediately, Korean customs and review officers may require time to update internal procedures. Early submissions should include clear cross-references between device components, material certifications, and the relevant clauses of GB/T 24625-2025 to support smooth processing.

Prepare Documentation and Supply Chain Traceability

Manufacturers should consolidate material test reports, supplier declarations, and batch-level compliance records aligned with GB/T 24625-2025. Maintaining auditable traceability from raw material to finished device strengthens submission credibility and reduces post-submission queries.

Editorial Perspective / Industry Observation

Observably, this update reflects MFDS’s incremental alignment with internationally referenced technical standards — particularly those emerging from major manufacturing economies. Analysis shows it is less a broad harmonization move and more a targeted efficiency measure focused on one high-value material category within a niche device class. From an industry perspective, the change signals growing recognition of China’s evolving medical-grade material standardization capacity — but remains narrowly scoped and conditional. Current relevance lies primarily in accelerated clearance for a defined subset of imports, rather than systemic regulatory convergence.

It is more appropriately understood as a procedural optimization than a strategic policy shift. Sustained impact depends on consistent enforcement, clarity in evidentiary expectations, and potential future expansion to adjacent standards or material types — none of which are indicated in the current notice.

Conclusion
This MFDS update introduces a concrete, time-saving pathway for certain smart orthotics entering Korea — contingent on strict adherence to GB/T 24625-2025. Its significance is operational rather than transformative: it reduces administrative latency for compliant actors but does not alter fundamental classification, clinical evaluation, or quality system requirements. For stakeholders, the event is best interpreted as a tactical opportunity requiring precise documentation and supply chain coordination — not a signal of broader regulatory liberalization.

Information Source
Main source: Korean Ministry of Food and Drug Safety (MFDS), Smart Orthotics Import Compliance Notice (updated May 17, 2026).
Note: Ongoing observation is recommended for any supplementary guidance or interpretation documents issued by MFDS or Korean notified bodies regarding evidentiary requirements or scope clarification.